Premium
Elanco Animal Health Incorporated (ELAN)
NYSE
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Rajeev ModiExec. VP of U.S. Pet Health & Global Digital Transformation | 4,91k | 99,94k | Achat | 20,35 | 160,81k | 3,15% |
| 2026-05-15 | Mr. Jeffrey N. SimmonsPresident, CEO & Director | 4,97k | 99,84k | Achat | 20,09 | 1,87M | 0,27% |
| 2026-04-01 | Dr. Ellen de BrabanderExec. VP of Research, Development & Regulatory Affairs | -20,29k | 469,06k | Sale to Issuer | 23,12 | 211,13k | -8,77% |
| 2026-03-03 | Mr. Rajeev ModiExec. VP of U.S. Pet Health & Global Digital Transformation | -4,39k | 109,27k | Sale to Issuer | 24,88 | 155,90k | -2,74% |
| 2026-03-03 | Ms. Shiv O'NeillExec. VP, General Counsel & Corporate Secretary | -4,74k | 117,88k | Sale to Issuer | 24,88 | 83,83k | -5,35% |
| 2026-03-03 | Mr. Jeffrey N. SimmonsPresident, CEO & Director | -37,90k | 942,90k | Sale to Issuer | 24,88 | 1,86M | -2,00% |
| 2026-03-03 | Mr. Timothy J. BettingtonExec. VP of Center of Strategic Growth | -4,70k | 116,81k | Sale to Issuer | 24,88 | 105,88k | -4,25% |
| 2026-03-03 | Dr. Ramiro Martin CabralExec. VP & President of Elanco International | -6,49k | 161,52k | Sale to Issuer | 24,88 | 224,13k | -2,81% |
| 2026-03-03 | Dr. Jose Manuel Correia de SimasExec. VP of US Farm Animal Business | -3,37k | 83,87k | Sale to Issuer | 24,88 | 71,54k | -4,50% |
| 2026-03-03 | Dr. Ellen de BrabanderExec. VP of Research, Development & Regulatory Affairs | -8,26k | 205,56k | Sale to Issuer | 24,88 | 190,43k | -4,16% |
| 2026-03-03 | Mr. David S. KinardExec. VP of HR, Corporate Communications & Administration | -3,43k | 85,41k | Sale to Issuer | 24,88 | 184,86k | -1,82% |
| 2026-03-03 | Ms. Grace McArdleExec. VP of Manufacturing & Quality | -4,32k | 107,53k | Sale to Issuer | 24,88 | 103,71k | -4,00% |
| 2026-03-03 | Mr. James M. MeerSenior VP & CAO | -1,39k | 34,56k | Sale to Issuer | 24,88 | 66,73k | -2,04% |
| 2026-03-01 | Mr. James M. MeerSenior VP & CAO | -4,79k | 126,38k | Sale to Issuer | 26,40 | 47,74k | -9,11% |
| 2026-03-01 | Mr. Rajeev ModiExec. VP of U.S. Pet Health & Global Digital Transformation | -19,38k | 511,50k | Sale to Issuer | 26,40 | 110,80k | -14,88% |
| 2026-03-01 | Mr. Jeffrey N. SimmonsPresident, CEO & Director | -229,98k | 6,07M | Sale to Issuer | 26,40 | 1,81M | -11,27% |
| 2026-03-01 | Dr. Jose Manuel Correia de SimasExec. VP of US Farm Animal Business | -9,88k | 260,91k | Sale to Issuer | 26,40 | 67,54k | -12,76% |
| 2026-03-01 | Dr. Ramiro Martin CabralExec. VP & President of Elanco International | -30,15k | 795,96k | Sale to Issuer | 26,40 | 215,89k | -12,25% |
| 2026-03-01 | Mr. David S. KinardExec. VP of HR, Corporate Communications & Administration | -15,38k | 405,95k | Sale to Issuer | 26,40 | 180,92k | -7,83% |
| 2026-03-01 | Ms. Grace McArdleExec. VP of Manufacturing & Quality | -12,34k | 325,70k | Sale to Issuer | 26,40 | 108,03k | -10,25% |
| 2026-03-01 | Ms. Shiv O'NeillExec. VP, General Counsel & Corporate Secretary | -13,11k | 346,13k | Sale to Issuer | 26,40 | 88,57k | -12,89% |
| 2026-03-01 | Dr. Ellen de BrabanderExec. VP of Research, Development & Regulatory Affairs | -46,28k | 1,22M | Sale to Issuer | 26,40 | 181,84k | -20,29% |
| 2026-03-01 | Mr. Timothy J. BettingtonExec. VP of Center of Strategic Growth | -18,10k | 477,79k | Sale to Issuer | 26,40 | 100,26k | -15,29% |
| 2025-12-19 | Mr. Roy David HooverInitié | -60,00k | 0,00 | Other Disposition | - | 180,92k | -24,90% |
| 2025-12-12 | Mr. Lawrence E. KurziusIndependent Chairman | 10,00k | 213,00k | Achat | 21,30 | 40,00k | 33,33% |
| 2025-12-11 | Mr. Rajeev ModiExec. VP of U.S. Pet Health & Global Digital Transformation | 4,50k | 95,99k | Achat | 21,33 | 73,47k | 6,52% |
| 2025-12-11 | Mr. Robert M. VanHimbergenExec. VP & CFO | 6,95k | 150,43k | Achat | 21,64 | 14,38k | 93,59% |
| 2025-12-11 | Mr. Jeffrey N. SimmonsPresident, CEO & Director | 22,00k | 478,50k | Achat | 21,75 | 1,87M | 1,19% |
| 2025-07-03 | Mr. James M. MeerSenior VP & CAO | -1,16k | 17,00k | Sale to Issuer | 14,64 | 34,37k | -3,27% |
| 2025-07-03 | Ms. Grace McArdleExec. VP of Manufacturing & Quality | -4,35k | 63,63k | Sale to Issuer | 14,64 | 76,05k | -5,41% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
